Comments from NRDC Senior Scientist Jennifer Sass to External Peer Review Meeting for Report on Physiologically Based Pharmacokinetic (PBPK) Modeling for Chloroprene (Ramboll, 2020)

October 05, 2020

Comments from NRDC pointing out flaws and uncertainties with the model sponsored by chloroprene chemical manufacturer, Denka. If used, the model would weaken the EPA cancer evaluation for chloroprene, and continue to deny protections for communities in ‘cancer alley’ Louisiana from chloroprene air pollution.